| 0 |
DRUG INEFFECTIVE |
53 |
| 1 |
NEUROLEPTIC MALIGNANT SYNDROME |
42 |
| 2 |
SEDATION |
38 |
| 3 |
DRUG INTERACTION |
35 |
| 4 |
AKATHISIA |
32 |
| 5 |
PARKINSONISM |
31 |
| 6 |
WEIGHT INCREASED |
31 |
| 7 |
DYSTONIA |
26 |
| 8 |
CONSTIPATION |
25 |
| 9 |
DELUSION |
25 |
| 10 |
ABNORMAL BEHAVIOUR |
24 |
| 11 |
DYSKINESIA |
23 |
| 12 |
AGGRESSION |
21 |
| 13 |
EXTRAPYRAMIDAL DISORDER |
21 |
| 14 |
HYPERCHOLESTEROLAEMIA |
21 |
| 15 |
SUICIDE ATTEMPT |
20 |
| 16 |
TREMOR |
20 |
| 17 |
COGNITIVE DISORDER |
17 |
| 18 |
RHABDOMYOLYSIS |
17 |
| 19 |
DIABETES MELLITUS |
16 |
| 20 |
ORTHOSTATIC HYPERTENSION |
16 |
| 21 |
SCHIZOPHRENIA |
16 |
| 22 |
TREATMENT NONCOMPLIANCE |
16 |
| 23 |
GYNAECOMASTIA |
14 |
| 24 |
PSYCHOTIC DISORDER |
14 |
| 25 |
PYREXIA |
14 |
| 26 |
TOXICITY TO VARIOUS AGENTS |
14 |
| 27 |
HOSTILITY |
13 |
| 28 |
SOCIAL AVOIDANT BEHAVIOUR |
13 |
| 29 |
SUICIDAL IDEATION |
13 |
| 30 |
VISION BLURRED |
13 |
| 31 |
ANOSOGNOSIA |
12 |
| 32 |
ANXIETY |
12 |
| 33 |
BLOOD PROLACTIN ABNORMAL |
12 |
| 34 |
EMOTIONAL POVERTY |
12 |
| 35 |
MUSCULOSKELETAL STIFFNESS |
12 |
| 36 |
OVERDOSE |
12 |
| 37 |
SEXUAL DYSFUNCTION |
12 |
| 38 |
AGITATION |
11 |
| 39 |
APATHY |
11 |
| 40 |
BLUNTED AFFECT |
11 |
| 41 |
CHEST PAIN |
11 |
| 42 |
DYSLIPIDAEMIA |
11 |
| 43 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
11 |
| 44 |
OFF LABEL USE |
11 |
| 45 |
ADVERSE DRUG REACTION |
10 |
| 46 |
BLOOD PROLACTIN INCREASED |
10 |
| 47 |
GRANULOCYTOPENIA |
10 |
| 48 |
SALIVARY HYPERSECRETION |
10 |
| 49 |
URINARY RETENTION |
10 |
| 50 |
CARDIAC ARREST |
9 |
| 51 |
CONDITION AGGRAVATED |
9 |
| 52 |
DYSPNOEA |
9 |
| 53 |
HALLUCINATION |
9 |
| 54 |
LETHARGY |
9 |
| 55 |
LEUKOPENIA |
9 |
| 56 |
CATATONIA |
8 |
| 57 |
DIZZINESS |
8 |
| 58 |
DYSPHAGIA |
8 |
| 59 |
FATIGUE |
8 |
| 60 |
GASTROINTESTINAL HAEMORRHAGE |
8 |
| 61 |
HYPONATRAEMIA |
8 |
| 62 |
MUSCLE RIGIDITY |
8 |
| 63 |
TARDIVE DYSKINESIA |
8 |
| 64 |
TREATMENT FAILURE |
8 |
| 65 |
ACCOMMODATION DISORDER |
7 |
| 66 |
DRUG ABUSE |
7 |
| 67 |
DRUG EFFECT INCOMPLETE |
7 |
| 68 |
DYSARTHRIA |
7 |
| 69 |
FALL |
7 |
| 70 |
FLATULENCE |
7 |
| 71 |
HYPERTENSION |
7 |
| 72 |
INSOMNIA |
7 |
| 73 |
NEUTROPENIA |
7 |
| 74 |
PSYCHIATRIC DECOMPENSATION |
7 |
| 75 |
RESPIRATORY FAILURE |
7 |
| 76 |
SEIZURE |
7 |
| 77 |
TACHYCARDIA |
7 |
| 78 |
UNDERDOSE |
7 |
| 79 |
WEIGHT DECREASED |
7 |
| 80 |
CAMPTOCORMIA |
6 |
| 81 |
DIARRHOEA |
6 |
| 82 |
GAIT DISTURBANCE |
6 |
| 83 |
HYPERHIDROSIS |
6 |
| 84 |
HYPOTENSION |
6 |
| 85 |
LOSS OF CONSCIOUSNESS |
6 |
| 86 |
MYOCARDITIS |
6 |
| 87 |
PERFORATED ULCER |
6 |
| 88 |
RASH PRURITIC |
6 |
| 89 |
SOMNOLENCE |
6 |
| 90 |
VOMITING |
6 |
| 91 |
WITHDRAWAL SYNDROME |
6 |
| 92 |
ABDOMINAL PAIN UPPER |
5 |
| 93 |
ATRIAL FIBRILLATION |
5 |
| 94 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
5 |
| 95 |
CONVULSION |
5 |
| 96 |
DEHYDRATION |
5 |
| 97 |
DRUG DEPENDENCE |
5 |
| 98 |
ELECTROCARDIOGRAM QT PROLONGED |
5 |
| 99 |
HYPERGLYCAEMIA |
5 |
| 100 |
METABOLIC DISORDER |
5 |
| 101 |
MUSCLE TWITCHING |
5 |
| 102 |
NAUSEA |
5 |
| 103 |
OEDEMA |
5 |
| 104 |
PAIN IN EXTREMITY |
5 |
| 105 |
PNEUMONIA |
5 |
| 106 |
RESTLESSNESS |
5 |
| 107 |
SEPSIS |
5 |
| 108 |
SUDDEN DEATH |
5 |
| 109 |
THERAPEUTIC RESPONSE DECREASED |
5 |
| 110 |
TYPE 2 DIABETES MELLITUS |
5 |
| 111 |
WRONG DRUG ADMINISTERED |
5 |
| 112 |
ACCIDENTAL OVERDOSE |
4 |
| 113 |
ARTHRALGIA |
4 |
| 114 |
ASTHENIA |
4 |
| 115 |
BRADYKINESIA |
4 |
| 116 |
CARDIO-RESPIRATORY ARREST |
4 |
| 117 |
COMA |
4 |
| 118 |
COUGH |
4 |
| 119 |
DEPRESSION |
4 |
| 120 |
DRUG INTOLERANCE |
4 |
| 121 |
DRUG RESISTANCE |
4 |
| 122 |
DRY MOUTH |
4 |
| 123 |
GALACTORRHOEA |
4 |
| 124 |
HALLUCINATION, AUDITORY |
4 |
| 125 |
HYPERAMMONAEMIC ENCEPHALOPATHY |
4 |
| 126 |
INJECTION SITE PAIN |
4 |
| 127 |
LUNG DISORDER |
4 |
| 128 |
MEDICATION ERROR |
4 |
| 129 |
MUTISM |
4 |
| 130 |
MYOCARDIAL INFARCTION |
4 |
| 131 |
NEPHROGENIC DIABETES INSIPIDUS |
4 |
| 132 |
PANCREATITIS NECROTISING |
4 |
| 133 |
PERSONALITY CHANGE |
4 |
| 134 |
PRODUCT DOSE OMISSION ISSUE |
4 |
| 135 |
PRURITUS |
4 |
| 136 |
PSYCHOMOTOR HYPERACTIVITY |
4 |
| 137 |
PULMONARY EMBOLISM |
4 |
| 138 |
PULMONARY OEDEMA |
4 |
| 139 |
RENAL IMPAIRMENT |
4 |
| 140 |
RESPIRATORY DEPRESSION |
4 |
| 141 |
SYNCOPE |
4 |
| 142 |
TACHYPNOEA |
4 |
| 143 |
ABDOMINAL PAIN |
3 |
| 144 |
AGRANULOCYTOSIS |
3 |
| 145 |
AMNESIA |
3 |
| 146 |
ANAEMIA |
3 |
| 147 |
ANAL INCONTINENCE |
3 |
| 148 |
APHASIA |
3 |
| 149 |
ARTERIOSCLEROSIS |
3 |
| 150 |
BLOOD TRIGLYCERIDES INCREASED |
3 |
| 151 |
BRADYCARDIA |
3 |
| 152 |
CARDIAC FAILURE |
3 |
| 153 |
CIRCULATORY COLLAPSE |
3 |
| 154 |
COMPLETED SUICIDE |
3 |
| 155 |
CONDUCTION DISORDER |
3 |
| 156 |
CONFUSIONAL STATE |
3 |
| 157 |
DEATH |
3 |
| 158 |
DECREASED APPETITE |
3 |
| 159 |
DELIRIUM |
3 |
| 160 |
DISTURBANCE IN ATTENTION |
3 |
| 161 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
3 |
| 162 |
DYSURIA |
3 |
| 163 |
EPILEPSY |
3 |
| 164 |
FEELING ABNORMAL |
3 |
| 165 |
HAEMODYNAMIC INSTABILITY |
3 |
| 166 |
HYPERTRIGLYCERIDAEMIA |
3 |
| 167 |
ILEUS |
3 |
| 168 |
INTENTIONAL SELF-INJURY |
3 |
| 169 |
IRRITABILITY |
3 |
| 170 |
MENTAL DISORDER |
3 |
| 171 |
MENTAL STATUS CHANGES |
3 |
| 172 |
MOVEMENT DISORDER |
3 |
| 173 |
NEUROMUSCULAR TOXICITY |
3 |
| 174 |
OROPHARYNGEAL PAIN |
3 |
| 175 |
PANCREATITIS HAEMORRHAGIC |
3 |
| 176 |
PARANOIA |
3 |
| 177 |
PNEUMONIA ASPIRATION |
3 |
| 178 |
PRODUCT ADMINISTRATION ERROR |
3 |
| 179 |
PRODUCT QUALITY ISSUE |
3 |
| 180 |
RASH |
3 |
| 181 |
RENAL DISORDER |
3 |
| 182 |
SINUS TACHYCARDIA |
3 |
| 183 |
SMALL INTESTINAL OBSTRUCTION |
3 |
| 184 |
SUBSTANCE ABUSE |
3 |
| 185 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
3 |
| 186 |
THERAPY NON-RESPONDER |
3 |
| 187 |
THERAPY PARTIAL RESPONDER |
3 |
| 188 |
THINKING ABNORMAL |
3 |
| 189 |
TORSADE DE POINTES |
3 |
| 190 |
URINARY INCONTINENCE |
3 |
| 191 |
VISUAL ACUITY REDUCED |
3 |
| 192 |
VISUAL IMPAIRMENT |
3 |
| 193 |
WHITE BLOOD CELL COUNT INCREASED |
3 |
| 194 |
ABASIA |
2 |
| 195 |
ABDOMINAL DISCOMFORT |
2 |
| 196 |
ACIDOSIS |
2 |
| 197 |
ACUTE KIDNEY INJURY |
2 |
| 198 |
ADVERSE EVENT |
2 |
| 199 |
AFFECTIVE DISORDER |
2 |
| 200 |
ALCOHOL USE |
2 |
| 201 |
ALOPECIA |
2 |
| 202 |
ALTERED STATE OF CONSCIOUSNESS |
2 |
| 203 |
ANGER |
2 |
| 204 |
ANTICONVULSANT DRUG LEVEL DECREASED |
2 |
| 205 |
APPLICATION SITE ERYTHEMA |
2 |
| 206 |
ARRHYTHMIA |
2 |
| 207 |
BACK PAIN |
2 |
| 208 |
BIPOLAR DISORDER |
2 |
| 209 |
BIPOLAR I DISORDER |
2 |
| 210 |
BLOOD CHLORIDE DECREASED |
2 |
| 211 |
BLOOD GLUCOSE INCREASED |
2 |
| 212 |
BLOOD PRESSURE DECREASED |
2 |
| 213 |
BRADYPNOEA |
2 |
| 214 |
BRAIN OEDEMA |
2 |
| 215 |
CACHEXIA |
2 |
| 216 |
CARDIAC FAILURE CONGESTIVE |
2 |
| 217 |
CATARACT |
2 |
| 218 |
CHROMATURIA |
2 |
| 219 |
COMMUNICATION DISORDER |
2 |
| 220 |
CONJUNCTIVITIS |
2 |
| 221 |
COORDINATION ABNORMAL |
2 |
| 222 |
COPROLALIA |
2 |
| 223 |
COVID-19 |
2 |
| 224 |
DECREASED ACTIVITY |
2 |
| 225 |
DELUSIONAL PERCEPTION |
2 |
| 226 |
DEPRESSED MOOD |
2 |
| 227 |
DIABETIC COMA |
2 |
| 228 |
DIABETIC KETOACIDOSIS |
2 |
| 229 |
DIET REFUSAL |
2 |
| 230 |
DISEASE PROGRESSION |
2 |
| 231 |
DISINHIBITION |
2 |
| 232 |
DISORIENTATION |
2 |
| 233 |
DROOLING |
2 |
| 234 |
DRUG DOSE OMISSION |
2 |
| 235 |
DRUG EFFECT DECREASED |
2 |
| 236 |
DRUG LEVEL DECREASED |
2 |
| 237 |
DRUG LEVEL INCREASED |
2 |
| 238 |
DYSPEPSIA |
2 |
| 239 |
DYSPHORIA |
2 |
| 240 |
EATING DISORDER |
2 |
| 241 |
ENCEPHALOPATHY |
2 |
| 242 |
EXPIRED PRODUCT ADMINISTERED |
2 |
| 243 |
FEAR |
2 |
| 244 |
FEEDING DISORDER |
2 |
| 245 |
FLUID INTAKE REDUCED |
2 |
| 246 |
FOLATE DEFICIENCY |
2 |
| 247 |
HAEMATEMESIS |
2 |
| 248 |
HAEMATOCRIT DECREASED |
2 |
| 249 |
HAEMOGLOBIN DECREASED |
2 |
| 250 |
HEADACHE |
2 |
| 251 |
HEPATITIS FULMINANT |
2 |
| 252 |
HYPERKALAEMIA |
2 |
| 253 |
HYPERPROLACTINAEMIA |
2 |
| 254 |
HYPERTONIA |
2 |
| 255 |
HYPOAESTHESIA |
2 |
| 256 |
HYPOKALAEMIA |
2 |
| 257 |
HYPOTHYROIDISM |
2 |
| 258 |
HYPOXIA |
2 |
| 259 |
INCOHERENT |
2 |
| 260 |
INCORRECT DOSE ADMINISTERED |
2 |
| 261 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
2 |
| 262 |
INCREASED APPETITE |
2 |
| 263 |
INJECTION SITE ERYTHEMA |
2 |
| 264 |
JOINT SWELLING |
2 |
| 265 |
KETONURIA |
2 |
| 266 |
LEUKOCYTOSIS |
2 |
| 267 |
LOGORRHOEA |
2 |
| 268 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
2 |
| 269 |
LOWER RESPIRATORY TRACT INFECTION |
2 |
| 270 |
MANIA |
2 |
| 271 |
MATERNAL EXPOSURE DURING PREGNANCY |
2 |
| 272 |
MENTAL IMPAIRMENT |
2 |
| 273 |
METABOLIC ACIDOSIS |
2 |
| 274 |
MOOD SWINGS |
2 |
| 275 |
MOTOR DYSFUNCTION |
2 |
| 276 |
MUSCULAR WEAKNESS |
2 |
| 277 |
MYALGIA |
2 |
| 278 |
MYOCARDIAL NECROSIS MARKER INCREASED |
2 |
| 279 |
MYOPATHY TOXIC |
2 |
| 280 |
NEGATIVISM |
2 |
| 281 |
NERVOUSNESS |
2 |
| 282 |
NEUTROPHIL COUNT DECREASED |
2 |
| 283 |
NO THERAPEUTIC RESPONSE |
2 |
| 284 |
OLIGOMENORRHOEA |
2 |
| 285 |
ORTHOSTATIC HYPOTENSION |
2 |
| 286 |
OXYGEN SATURATION DECREASED |
2 |
| 287 |
PAIN |
2 |
| 288 |
PALPITATIONS |
2 |
| 289 |
PANCREATITIS |
2 |
| 290 |
PARKINSON^S DISEASE |
2 |
| 291 |
PERICARDITIS CONSTRICTIVE |
2 |
| 292 |
PERSECUTORY DELUSION |
2 |
| 293 |
PERSONALITY DISORDER |
2 |
| 294 |
PNEUMONITIS |
2 |
| 295 |
POLYDIPSIA |
2 |
| 296 |
POLYURIA |
2 |
| 297 |
PRIAPISM |
2 |
| 298 |
PRODUCT USE IN UNAPPROVED INDICATION |
2 |
| 299 |
RED BLOOD CELL COUNT DECREASED |
2 |
| 300 |
REFUSAL OF TREATMENT BY PATIENT |
2 |
| 301 |
SCHIZOAFFECTIVE DISORDER BIPOLAR TYPE |
2 |
| 302 |
SCREAMING |
2 |
| 303 |
SELF-INJURIOUS IDEATION |
2 |
| 304 |
SPEECH DISORDER |
2 |
| 305 |
TENSION |
2 |
| 306 |
THERAPEUTIC RESPONSE UNEXPECTED |
2 |
| 307 |
TIC |
2 |
| 308 |
TROPONIN INCREASED |
2 |
| 309 |
UNEVALUABLE EVENT |
2 |
| 310 |
UNRESPONSIVE TO STIMULI |
2 |
| 311 |
VERTIGO |
2 |
| 312 |
WHITE BLOOD CELL COUNT DECREASED |
2 |
| 313 |
ABDOMINAL DISTENSION |
1 |
| 314 |
ABNORMAL DREAMS |
1 |
| 315 |
ABNORMAL SLEEP-RELATED EVENT |
1 |
| 316 |
ACROCHORDON |
1 |
| 317 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
1 |
| 318 |
ACUTE RESPIRATORY FAILURE |
1 |
| 319 |
AGRAPHIA |
1 |
| 320 |
AKINESIA |
1 |
| 321 |
ALCOHOL POISONING |
1 |
| 322 |
ANAEMIA MEGALOBLASTIC |
1 |
| 323 |
ANAPHYLACTOID REACTION |
1 |
| 324 |
ANOREXIA |
1 |
| 325 |
ANTICONVULSANT DRUG LEVEL INCREASED |
1 |
| 326 |
ANTISOCIAL BEHAVIOUR |
1 |
| 327 |
APALLIC SYNDROME |
1 |
| 328 |
APPLICATION SITE PRURITUS |
1 |
| 329 |
ARTERIAL OCCLUSIVE DISEASE |
1 |
| 330 |
ARTERIOSCLEROSIS CORONARY ARTERY |
1 |
| 331 |
ARTHROPATHY |
1 |
| 332 |
ASPHYXIA |
1 |
| 333 |
ASPIRATION |
1 |
| 334 |
ATRIOVENTRICULAR BLOCK COMPLETE |
1 |
| 335 |
ATTENTION DEFICIT/HYPERACTIVITY DISORDER |
1 |
| 336 |
AUTOMATISM |
1 |
| 337 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
1 |
| 338 |
AVERSION |
1 |
| 339 |
AZOTAEMIA |
1 |
| 340 |
BACTERIA URINE |
1 |
| 341 |
BACTERIAL INFECTION |
1 |
| 342 |
BEHAVIOUR DISORDER |
1 |
| 343 |
BLEPHAROSPASM |
1 |
| 344 |
BLINDNESS UNILATERAL |
1 |
| 345 |
BLOOD CHOLESTEROL INCREASED |
1 |
| 346 |
BLOOD CREATINE PHOSPHOKINASE ABNORMAL |
1 |
| 347 |
BLOOD CREATININE INCREASED |
1 |
| 348 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
| 349 |
BLOOD POTASSIUM INCREASED |
1 |
| 350 |
BLOOD PRESSURE INADEQUATELY CONTROLLED |
1 |
| 351 |
BLOOD SODIUM DECREASED |
1 |
| 352 |
BLOOD UREA INCREASED |
1 |
| 353 |
BODY MASS INDEX INCREASED |
1 |
| 354 |
BONE MARROW DISORDER |
1 |
| 355 |
BONE MARROW FAILURE |
1 |
| 356 |
BONE PAIN |
1 |
| 357 |
BRADYPHRENIA |
1 |
| 358 |
BREAST CANCER |
1 |
| 359 |
C-REACTIVE PROTEIN INCREASED |
1 |
| 360 |
CARDIAC ENZYMES INCREASED |
1 |
| 361 |
CARDIOGENIC SHOCK |
1 |
| 362 |
CARDIOTOXICITY |
1 |
| 363 |
CEREBROVASCULAR ACCIDENT |
1 |
| 364 |
CHILLS |
1 |
| 365 |
COAGULATION FACTOR DECREASED |
1 |
| 366 |
COGWHEEL RIGIDITY |
1 |
| 367 |
COLONIC PSEUDO-OBSTRUCTION |
1 |
| 368 |
COMPARTMENT SYNDROME |
1 |
| 369 |
CONGENITAL ANOMALY |
1 |
| 370 |
CONTUSION |
1 |
| 371 |
CORNEAL DEPOSITS |
1 |
| 372 |
CORNEAL OEDEMA |
1 |
| 373 |
CORNEAL PIGMENTATION |
1 |
| 374 |
CORONARY ARTERY DISEASE |
1 |
| 375 |
CYANOSIS |
1 |
| 376 |
CYCLOTHYMIC DISORDER |
1 |
| 377 |
DELUSION OF GRANDEUR |
1 |
| 378 |
DEPENDENCE |
1 |
| 379 |
DEREALISATION |
1 |
| 380 |
DERMATITIS CONTACT |
1 |
| 381 |
DIABETES INSIPIDUS |
1 |
| 382 |
DIABETIC NEUROPATHY |
1 |
| 383 |
DILATATION VENTRICULAR |
1 |
| 384 |
DIPLOPIA |
1 |
| 385 |
DISCOMFORT |
1 |
| 386 |
DISORGANISED SPEECH |
1 |
| 387 |
DISSOCIATION |
1 |
| 388 |
DRUG ADMINISTERED IN WRONG DEVICE |
1 |
| 389 |
DRUG ADMINISTRATION ERROR |
1 |
| 390 |
DRUG DISPENSING ERROR |
1 |
| 391 |
DRUG INTERACTION POTENTIATION |
1 |
| 392 |
DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED |
1 |
| 393 |
DRUG TOLERANCE |
1 |
| 394 |
DRUG TOXICITY |
1 |
| 395 |
DRY SKIN |
1 |
| 396 |
DYSGRAPHIA |
1 |
| 397 |
DYSPNOEA EXERTIONAL |
1 |
| 398 |
DYSSTASIA |
1 |
| 399 |
ECZEMA |
1 |
| 400 |
EJECTION FRACTION DECREASED |
1 |
| 401 |
ELECTROLYTE IMBALANCE |
1 |
| 402 |
EMBOLIA CUTIS MEDICAMENTOSA |
1 |
| 403 |
EMOTIONAL DISTRESS |
1 |
| 404 |
EOSINOPHILIA |
1 |
| 405 |
ERECTILE DYSFUNCTION |
1 |
| 406 |
EYE MOVEMENT DISORDER |
1 |
| 407 |
EYELID OEDEMA |
1 |
| 408 |
FAECAL INCONTINENCE |
1 |
| 409 |
FAECALOMA |
1 |
| 410 |
FAECES HARD |
1 |
| 411 |
FEBRILE NEUTROPENIA |
1 |
| 412 |
FEELING HOT |
1 |
| 413 |
FEMORAL NECK FRACTURE |
1 |
| 414 |
FIBROSIS |
1 |
| 415 |
FINE MOTOR SKILL DYSFUNCTION |
1 |
| 416 |
FLAT AFFECT |
1 |
| 417 |
FLUSHING |
1 |
| 418 |
FRUSTRATION |
1 |
| 419 |
GALLBLADDER DISORDER |
1 |
| 420 |
GENERAL PHYSICAL CONDITION ABNORMAL |
1 |
| 421 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
| 422 |
GENERALISED ANXIETY DISORDER |
1 |
| 423 |
GENERALISED OEDEMA |
1 |
| 424 |
GINGIVAL BLEEDING |
1 |
| 425 |
GINGIVAL HYPERTROPHY |
1 |
| 426 |
GRAND MAL CONVULSION |
1 |
| 427 |
HALLUCINATION, VISUAL |
1 |
| 428 |
HEAD DISCOMFORT |
1 |
| 429 |
HEAD INJURY |
1 |
| 430 |
HEART RATE INCREASED |
1 |
| 431 |
HEMIPLEGIA |
1 |
| 432 |
HEPATITIS |
1 |
| 433 |
HEPATOCELLULAR DAMAGE |
1 |
| 434 |
HOSPITALISATION |
1 |
| 435 |
HYPERAMMONAEMIA |
1 |
| 436 |
HYPERCOAGULATION |
1 |
| 437 |
HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME |
1 |
| 438 |
HYPEROSMOLAR HYPERGLYCAEMIC STATE |
1 |
| 439 |
HYPERSENSITIVITY |
1 |
| 440 |
HYPERTRANSAMINASAEMIA |
1 |
| 441 |
HYPOCALCAEMIA |
1 |
| 442 |
HYPOGLYCAEMIA |
1 |
| 443 |
HYPOKINESIA |
1 |
| 444 |
HYPOMANIA |
1 |
| 445 |
HYPOOSMOLAR STATE |
1 |
| 446 |
HYPOPHAGIA |
1 |
| 447 |
HYPOPROTEINAEMIA |
1 |
| 448 |
HYPOVENTILATION |
1 |
| 449 |
HYPOVOLAEMIA |
1 |
| 450 |
HYSTERICAL PSYCHOSIS |
1 |
| 451 |
IDEAS OF REFERENCE |
1 |
| 452 |
ILL-DEFINED DISORDER |
1 |
| 453 |
ILLNESS ANXIETY DISORDER |
1 |
| 454 |
ILLUSION |
1 |
| 455 |
INABILITY TO AFFORD MEDICATION |
1 |
| 456 |
INAPPROPRIATE AFFECT |
1 |
| 457 |
INCONTINENCE |
1 |
| 458 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
| 459 |
INFECTION |
1 |
| 460 |
INFLUENZA LIKE ILLNESS |
1 |
| 461 |
INITIAL INSOMNIA |
1 |
| 462 |
INJECTION SITE MASS |
1 |
| 463 |
INTENTIONAL DRUG MISUSE |
1 |
| 464 |
INTENTIONAL OVERDOSE |
1 |
| 465 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
| 466 |
INTESTINAL PSEUDO-OBSTRUCTION |
1 |
| 467 |
JUDGEMENT IMPAIRED |
1 |
| 468 |
KETOSIS |
1 |
| 469 |
LABELLED DRUG-DRUG INTERACTION ISSUE |
1 |
| 470 |
LACERATION |
1 |
| 471 |
LEFT VENTRICULAR DYSFUNCTION |
1 |
| 472 |
LENTICULAR OPACITIES |
1 |
| 473 |
LIMB INJURY |
1 |
| 474 |
LIVER DISORDER |
1 |
| 475 |
LIVER INJURY |
1 |
| 476 |
LOCALISED INFECTION |
1 |
| 477 |
LUNG INFILTRATION |
1 |
| 478 |
LYMPHADENOPATHY |
1 |
| 479 |
LYMPHOCYTE COUNT DECREASED |
1 |
| 480 |
MACULAR DEGENERATION |
1 |
| 481 |
MACULOPATHY |
1 |
| 482 |
MALAISE |
1 |
| 483 |
MALNUTRITION |
1 |
| 484 |
MARKEDLY REDUCED DIETARY INTAKE |
1 |
| 485 |
MASTITIS |
1 |
| 486 |
MEMORY IMPAIRMENT |
1 |
| 487 |
MENSTRUAL DISORDER |
1 |
| 488 |
MICTURITION DISORDER |
1 |
| 489 |
MOBILITY DECREASED |
1 |
| 490 |
MONOPLEGIA |
1 |
| 491 |
MOOD ALTERED |
1 |
| 492 |
MOUTH SWELLING |
1 |
| 493 |
MUCOSAL INFLAMMATION |
1 |
| 494 |
MULTIPLE DRUG OVERDOSE |
1 |
| 495 |
MUSCLE DISORDER |
1 |
| 496 |
MUSCLE SPASMS |
1 |
| 497 |
MUSCLE TIGHTNESS |
1 |
| 498 |
MUSCULOSKELETAL PAIN |
1 |
| 499 |
MYOCARDIAL ISCHAEMIA |
1 |
| 500 |
NASOPHARYNGITIS |
1 |
| 501 |
NECK PAIN |
1 |
| 502 |
NEGATIVE THOUGHTS |
1 |
| 503 |
NEOPLASM PROGRESSION |
1 |
| 504 |
NERVE INJURY |
1 |
| 505 |
NERVOUS SYSTEM DISORDER |
1 |
| 506 |
NEUROPATHY PERIPHERAL |
1 |
| 507 |
NEUROTOXICITY |
1 |
| 508 |
NICOTINE DEPENDENCE |
1 |
| 509 |
NO ADVERSE EVENT |
1 |
| 510 |
NON-SMALL CELL LUNG CANCER |
1 |
| 511 |
OBESITY |
1 |
| 512 |
OBSTRUCTION GASTRIC |
1 |
| 513 |
OEDEMA PERIPHERAL |
1 |
| 514 |
ONYCHOCLASIS |
1 |
| 515 |
PANCREATIC HAEMORRHAGE |
1 |
| 516 |
PANCREATITIS ACUTE |
1 |
| 517 |
PANIC ATTACK |
1 |
| 518 |
PAPILLOEDEMA |
1 |
| 519 |
PARALYSIS |
1 |
| 520 |
PARKINSON'S DISEASE |
1 |
| 521 |
PARKINSONIAN GAIT |
1 |
| 522 |
PAROSMIA |
1 |
| 523 |
PATIENT DISSATISFACTION WITH TREATMENT |
1 |
| 524 |
PATIENT ELOPEMENT |
1 |
| 525 |
PERICARDITIS |
1 |
| 526 |
PETIT MAL EPILEPSY |
1 |
| 527 |
PHARMACEUTICAL PRODUCT COMPLAINT |
1 |
| 528 |
PHARYNGEAL ERYTHEMA |
1 |
| 529 |
PHARYNGOLARYNGEAL PAIN |
1 |
| 530 |
PHOTOPHOBIA |
1 |
| 531 |
PITUITARY TUMOUR BENIGN |
1 |
| 532 |
PLATELET AGGREGATION DECREASED |
1 |
| 533 |
PLATELET COUNT DECREASED |
1 |
| 534 |
PLATELET COUNT INCREASED |
1 |
| 535 |
PLEURAL EFFUSION |
1 |
| 536 |
POISONING |
1 |
| 537 |
POLLAKIURIA |
1 |
| 538 |
POOR PERSONAL HYGIENE |
1 |
| 539 |
POOR QUALITY SLEEP |
1 |
| 540 |
PRESCRIBED OVERDOSE |
1 |
| 541 |
PRESCRIBED UNDERDOSE |
1 |
| 542 |
PRESSURE OF SPEECH |
1 |
| 543 |
PRESYNCOPE |
1 |
| 544 |
PRODUCT AVAILABILITY ISSUE |
1 |
| 545 |
PRODUCT CONTAINER ISSUE |
1 |
| 546 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
1 |
| 547 |
PRODUCT LABEL CONFUSION |
1 |
| 548 |
PRODUCT PRESCRIBING ERROR |
1 |
| 549 |
PRODUCT PRESCRIBING ISSUE |
1 |
| 550 |
PRODUCT TAMPERING |
1 |
| 551 |
PRODUCT USE ISSUE |
1 |
| 552 |
PROSTATE INFECTION |
1 |
| 553 |
PROTHROMBIN TIME PROLONGED |
1 |
| 554 |
PROTRUSION TONGUE |
1 |
| 555 |
PSYCHIATRIC SYMPTOM |
1 |
| 556 |
PSYCHOMOTOR SKILLS IMPAIRED |
1 |
| 557 |
PULMONARY FIBROSIS |
1 |
| 558 |
PULMONARY INFARCTION |
1 |
| 559 |
PUPIL FIXED |
1 |
| 560 |
PYLORIC STENOSIS |
1 |
| 561 |
RASH MACULAR |
1 |
| 562 |
REBOUND PSYCHOSIS |
1 |
| 563 |
REFUSAL OF EXAMINATION |
1 |
| 564 |
RENAL FAILURE |
1 |
| 565 |
RESPIRATORY ALKALOSIS |
1 |
| 566 |
RESPIRATORY GAS EXCHANGE DISORDER |
1 |
| 567 |
RESPIRATORY TRACT INFECTION |
1 |
| 568 |
RESTLESS LEGS SYNDROME |
1 |
| 569 |
RETCHING |
1 |
| 570 |
RIGHT VENTRICULAR FAILURE |
1 |
| 571 |
SCAR |
1 |
| 572 |
SEBORRHOEA |
1 |
| 573 |
SEDATION COMPLICATION |
1 |
| 574 |
SELF-MEDICATION |
1 |
| 575 |
SICK SINUS SYNDROME |
1 |
| 576 |
SINUS ARRHYTHMIA |
1 |
| 577 |
SINUSITIS |
1 |
| 578 |
SKIN DISCOLOURATION |
1 |
| 579 |
SKIN EXFOLIATION |
1 |
| 580 |
SLEEP APNOEA SYNDROME |
1 |
| 581 |
SLEEP DISORDER |
1 |
| 582 |
SLEEP WALKING |
1 |
| 583 |
SMOKER |
1 |
| 584 |
SNEEZING |
1 |
| 585 |
SOLILOQUY |
1 |
| 586 |
SOMATIC SYMPTOM DISORDER |
1 |
| 587 |
SOMNAMBULISM |
1 |
| 588 |
SPINAL PAIN |
1 |
| 589 |
STEREOTYPY |
1 |
| 590 |
STUPOR |
1 |
| 591 |
SUBARACHNOID HAEMORRHAGE |
1 |
| 592 |
SUBSTANCE USE |
1 |
| 593 |
SUICIDAL BEHAVIOUR |
1 |
| 594 |
SWELLING OF EYELID |
1 |
| 595 |
SYMPTOM RECURRENCE |
1 |
| 596 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
1 |
| 597 |
TACHYPHRENIA |
1 |
| 598 |
TENDERNESS |
1 |
| 599 |
THERAPEUTIC AGENT TOXICITY |
1 |
| 600 |
THERAPEUTIC DRUG MONITORING ANALYSIS INCORRECTLY PERFORMED |
1 |
| 601 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
| 602 |
THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION |
1 |
| 603 |
THERAPY INTERRUPTED |
1 |
| 604 |
THERAPY RESPONDER |
1 |
| 605 |
THOUGHT INSERTION |
1 |
| 606 |
THROMBOCYTOPENIA |
1 |
| 607 |
TOURETTE^S DISORDER |
1 |
| 608 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
| 609 |
TRANSIENT PSYCHOSIS |
1 |
| 610 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
1 |
| 611 |
URINARY TRACT INFECTION |
1 |
| 612 |
URTICARIA |
1 |
| 613 |
VASCULAR DEVICE INFECTION |
1 |
| 614 |
VENTRICULAR TACHYCARDIA |
1 |
| 615 |
VIRAL INFECTION |
1 |
| 616 |
VISUAL DISTURBANCE |
1 |
| 617 |
VON WILLEBRAND'S DISEASE |
1 |
| 618 |
VULVOVAGINAL INJURY |
1 |
| 619 |
WEIGHT ABNORMAL |
1 |
| 620 |
WHEEZING |
1 |
| 621 |
WITHDRAWAL CATATONIA |
1 |
| 622 |
WOUND |
1 |
| 623 |
WOUND HAEMORRHAGE |
1 |
| 624 |
WRONG PRODUCT ADMINISTERED |
1 |